XuSheng Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
XuSheng Ma has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Haixue Zheng
State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
3 shared publications - Sk Mohiuddin Choudhury
Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
2 shared publications Ao Dong
Yunnan University
1 shared publication- Chuangfu Chen
College of Animal Science and Technology, Shihezi University, Shihezi, 832000, China.
1 shared publication Fagang Zhong
State Key Laboratory of Sheep Genetic Improvement and Healthy Production/Xinjiang Academy of Agricultural and Reclamation Sciences, Shihezi, Xinjiang 832000, CHINA
1 shared publication- Fan Lai
State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Center for Life Science, Yunnan Key Labora-tory of Cell Metabolism and Diseases,School of Life Sciences, Yunn
1 shared publication
Latest Publications
- Open Access
- 9 January 2024
- Published by Springer Nature in Research Square
Orally Available Small Molecule Regulates TXNIP Expression and Glucagon Action for the Treatment of Diabetes
In the progression of diabetes, sustained glucagon secretion facilitates glucose production. Despite its significance, no treatments currently target this vital parameter. We employed the promoter sequence of thioredoxin-interacting protein (TXNIP) as a screening target, evaluated our in-house chemical library, and subsequently undertook high-throughput screening and optimization via various medicinal chemistry techniques. Our efforts led to the identification of SKL-1223, an orally administered, non-toxic small molecule capable of effectively regulating blood glucose levels in both streptozotocin-induced and obesity-induced (db/db) diabetic mice. Furthermore, our study elucidated the hypoglycemic effect of glucagon and its role in reducing hepatic glucose output. On a mechanistic level, SKL-1223 interacts with the E-box region of the TXNIP promoter, consequently suppressing TXNIP transcription and associated signaling pathways. Thus, our study introduces a novel compound, offering a fresh therapeutic avenue for diabetes beyond existing regimens.
- 9 January 2024
- Published by Springer Nature in Research Square
Open AccessOrally Available Small Molecule Regulates TXNIP Expression and Glucagon Action for the Treatment of Diabetes
In the progression of diabetes, sustained glucagon secretion facilitates glucose production. Despite its significance, no treatments currently target this vital parameter. We employed the promoter sequence of thioredoxin-interacting protein (TXNIP) as a screening target, evaluated our in-house chemical library, and subsequently undertook high-throughput screening and optimization via various medicinal chemistry techniques. Our efforts led to the identification of SKL-1223, an orally administered, non-toxic small molecule capable of effectively regulating blood glucose levels in both streptozotocin-induced and obesity-induced (db/db) diabetic mice. Furthermore, our study elucidated the hypoglycemic effect of glucagon and its role in reducing hepatic glucose output. On a mechanistic level, SKL-1223 interacts with the E-box region of the TXNIP promoter, consequently suppressing TXNIP transcription and associated signaling pathways. Thus, our study introduces a novel compound, offering a fresh therapeutic avenue for diabetes beyond existing regimens.
- Open Access
- 22 June 2022
- Published by American Society for Microbiology in Journal of Virology
- Vol. 96 (12) , e0031722
FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication
FMDV is a pathogen that causes one of the world’s most destructive and highly contagious animal diseases. The FMDV 3A protein plays a critical role in viral replication and host range.
- 22 June 2022
- Published by American Society for Microbiology in Journal of Virology
- Vol. 96 (12) , e0031722
Open AccessFMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication
FMDV is a pathogen that causes one of the world’s most destructive and highly contagious animal diseases. The FMDV 3A protein plays a critical role in viral replication and host range.
- Open Access
- 1 March 2021
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 1145-1163
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
Inflammation refers to the response of the immune system to viral, bacterial, and fungal infections, or other foreign particles in the body, which can involve the production of a wide array of soluble inflammatory mediators. It is important for the development of many RNA virus-infected diseases. The primary factors through which the infection becomes inflammation involve inflammasome. Inflammasomes are proteins complex that the activation is responsive to specific pathogens, host cell damage, and other environmental stimuli. Inflammasomes bring about the maturation of various pro-inflammatory cytokines such as IL-18 and IL-1β in order to mediate the innate immune defense mechanisms. Many RNA viruses and their components, such as encephalomyocarditis virus (EMCV) 2B viroporin, the viral RNA of hepatitis C virus, the influenza virus M2 viroporin, the respiratory syncytial virus (RSV) small hydrophobic (SH) viroporin, and the human rhinovirus (HRV) 2B viroporin can activate the Nod-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome to influence the inflammatory response. On the other hand, several viruses use virus-encoded proteins to suppress inflammation activation, such as the influenza virus NS1 protein and the measles virus (MV) V protein. In this review, we summarize how RNA virus infection leads to the activation or inhibition of the NLRP3 inflammasome.
- 1 March 2021
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 1145-1163
Open AccessActivation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
Inflammation refers to the response of the immune system to viral, bacterial, and fungal infections, or other foreign particles in the body, which can involve the production of a wide array of soluble inflammatory mediators. It is important for the development of many RNA virus-infected diseases. The primary factors through which the infection becomes inflammation involve inflammasome. Inflammasomes are proteins complex that the activation is responsive to specific pathogens, host cell damage, and other environmental stimuli. Inflammasomes bring about the maturation of various pro-inflammatory cytokines such as IL-18 and IL-1β in order to mediate the innate immune defense mechanisms. Many RNA viruses and their components, such as encephalomyocarditis virus (EMCV) 2B viroporin, the viral RNA of hepatitis C virus, the influenza virus M2 viroporin, the respiratory syncytial virus (RSV) small hydrophobic (SH) viroporin, and the human rhinovirus (HRV) 2B viroporin can activate the Nod-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome to influence the inflammatory response. On the other hand, several viruses use virus-encoded proteins to suppress inflammation activation, such as the influenza virus NS1 protein and the measles virus (MV) V protein. In this review, we summarize how RNA virus infection leads to the activation or inhibition of the NLRP3 inflammasome.
- Open Access
- 1 January 2020
- Published by Kafkas University in Kafkas Universitesi Veteriner Fakultesi Dergisi
- Vol. 26 (3) , 377-384
Çin’de BVDV 1q’nun Tespiti: Patojenitesinin Araştırılması Amacıyla Genetik Karakterizasyon ve Deneysel Enfeksiyon
- 1 January 2020
- Published by Kafkas University in Kafkas Universitesi Veteriner Fakultesi Dergisi
- Vol. 26 (3) , 377-384
Open AccessÇin’de BVDV 1q’nun Tespiti: Patojenitesinin Araştırılması Amacıyla Genetik Karakterizasyon ve Deneysel Enfeksiyon